Search

Author/Creator Kessler, Yoel

1. A Pharmacokinetic Bioequivalence Study of Fremanezumab Administered Subcutaneously Using an Autoinjector and a Prefilled Syringe. Issue 9 (7th January 2021)

Authors:
Cherniakov, Irina; Cohen‐Barak, Orit; Tiver, Ryan; Gillespie, Michael; Kessler, Yoel; Gutierrez, Maria; Rasamoelisolo, Michele; Li, Shawn; Shen, Honglue; Hallak, Hussein; Loupe, Pippa S.; Smith, Michael; Rabinovich‐Guilatt, Laura; Spiegelstein, Ofer
Journal:
Clinical pharmacology in drug development
Issue:
Volume 10:Issue 9(2021)
Page Start:
1018
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach. (September 2021)

Authors:
Cohen-Barak, Orit; Radivojevic, Andrijana; Jones, Aksana; Fiedler-Kelly, Jill; Gillespie, Michael; Brennan, Michael; Gutman, Dikla; Rasamoelisolo, Michele; Hallak, Hussein; Loupe, Pippa; Kessler, Yoel; Ning, Xiaoping; Levi, Micha; Ahn, Andrew H; Rabinovich-Guilatt, Laura
Journal:
Cephalalgia
Issue:
Volume 41:Number 10(2021)
Page Start:
1065
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies. (July 2022)

Authors:
Diener, Hans Christoph; McAllister, Peter; Jürgens, Tim P; Kessler, Yoel; Ning, Xiaoping; Cohen, Joshua M; Campos, Verena Ramirez; Barash, Steve; Silberstein, Stephen D
Journal:
Cephalalgia
Issue:
Volume 42:Number 8(2022)
Page Start:
769
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗